Thromboprophylaxis
We recommend
Biosimilars in the Prophylaxis of Venous Thromboembolism
Nízkomolekulární hepariny jsou zlatým standardem antitrombotické profylaxe u chirurgických i interních pacientů. Od roku 2016 je v EU registrován první biosimilární enoxaparin – Inhixa. Italská studie přináší výsledky hodnocení jeho účinnosti a bezpečnosti v prevenci žilní tromboembolie v reálné klinické praxi i jejich porovnání se sdruženými daty u srovnatelné populace pacientů z klinických studií s originálním enoxaparinem.
Potential of Enoxaparin to Maintain A-V Shunt Patency According to the SEP Protocol
A newly published study by authors from Singapore focused on the ability of the SEP protocol –…
How to Navigate the Challenges of Anticoagulant Therapy in Pregnant Women − A Case Study
Every carrier of a mechanical heart valve is also on anticoagulant therapy. Warfarin is most…
Articles on this topic
Benefits of Enoxaparin Prophylaxis in Pregnancy and Postpartum
Study results suggest that the use of low molecular weight heparins during pregnancy could…
Enoxaparin in the Treatment of Pulmonary Embolism in a Morbidly Obese Patient – Case Report
The number of patients suffering from overweight and obesity has been steadily increasing in…
Optimization of Enoxaparin Dosing in Obese Patients
Obesity is a risk factor for venous thromboembolism; however, there is uncertainty regarding…
Comparison of Enoxaparin and Unfractionated Heparin in Hospitalized Patients in Terms of Clinical and Cost Effectiveness
Thromboembolic disease represents one of the severe complications in hospitalized patients.…
Weight-Based Enoxaparin Dosing vs. Standard Dosing in Trauma Patients
Thromboembolic disease is a common comorbidity in adult trauma patients, thus making routine…
Adequate Anti-Xa Levels Are More Often Achieved in Trauma Patients When Dosing Enoxaparin Based on Weight
Thromboembolic disease (TED) is a well-known preventable cause of morbidity and mortality in…
Dosing of Enoxaparin in Morbidly Obese Patients
How to optimally dose enoxaparin in morbidly obese patients? This question was addressed by a…
Clinical Characteristics of Trauma Patients Requiring Dosing Adjustments of Enoxaparin in TEN Prevention
Injuries and trauma surgical procedures represent a significant risk factor for the…
Efficacy and Safety of Enoxaparin as Bridging Anticoagulant Therapy After Ventricular Assist Device Implantation
The implantation of a ventricular assist device has become an increasingly common method in…
Administration of Low-Molecular-Weight Heparin After Hemorrhagic Stroke: What Is the Appropriate Timing?
Hemorrhagic stroke (HS) is a condition that raises doubts and concerns about anticoagulation.…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- Different doses of LMWH in hospitalized patients with COVID-19 – interim experience
- Low-Molecular-Weight Heparins in Thromboprophylaxis After Major Orthopedic and Traumatological Procedures According to Current Recommendations
- How to Manage Thromboprophylaxis in Obese and Extremely Obese Patients?
- Anticoagulants and Antiplatelets in the Treatment of Acute Coronary Syndromes
- Administration of Low-Molecular-Weight Heparin After Hemorrhagic Stroke: What Is the Appropriate Timing?
- Thromboprophylaxis with Enoxaparin Reduces Mortality in Patients Hospitalized with COVID-19
Journal on this topic
Related topic